Intrinsic Value of S&P & Nasdaq Contact Us

GreenLight Biosciences Holdings GRNAW NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
21/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — GRNAW

GreenLight Biosciences Holdings (GRNAW) and trades at $0.02. The 52-week range is 0.022-0.022.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-1.27, annual revenue of $6.38M.

The stock has a beta of 0.00, operates in the Healthcare sector.

Trading Data
Current Price$0.02
52-Week Range0.022-0.022
Volume550
Beta (1Y)0.00
Company
Employees280
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
CUSIP39536G113
Income (Latest Year)
Revenue$6.38M
Gross Profit$6.38M
EBITDA$-153.99M
Operating Income$-163.92M
Net Income$-167.06M
EPS$-1.27
EPS Diluted$-1.27
Shares Outstanding$131.98M
Balance Sheet (Latest Year)
Total Assets$148.6M
Current Assets$71.31M
Cash & ST Investments$68.1M
Total Liabilities$100.54M
Total Debt$80.48M
Net Debt$12.39M
Total Equity$48.06M
Debt / Equity1.67
Valuation Ratios
P/E Ratio-0
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message